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Abstract
NADPH-cytochrome P450 oxidoreductase (CPR) plays a central role in chemical detoxification and insecticide resistance in
Anopheles gambiae, the major vector for malaria. Anopheles gambiae CPR (AgCPR) was initially expressed in Eschericia coli
but failed to bind 29, 59-ADP Sepharose. To investigate this unusual trait, we expressed and purified a truncated histidine-
tagged version for side-by-side comparisons with human CPR. Close functional similarities were found with respect to the
steady state kinetics of cytochrome c reduction, with rates (kcat) of 105 s
21 and 88 s21, respectively, for mosquito and
human CPR. However, the inhibitory effects of 29,59-ADP on activity were different; the IC50 value of AgCPR for 29, 59 –ADP
was significantly higher (6–10 fold) than human CPR (hCPR) in both phosphate and phosphate-free buffer, indicative of a
decrease in affinity for 29, 59- ADP. This was confirmed by isothermal titration calorimetry where binding of 29,59-ADP to
AgCPR (Kd = 410618 nM) was ,10 fold weaker than human CPR (Kd = 38 nM). Characterisation of the individual AgFMN
binding domain revealed much weaker binding of FMN (Kd = 8362.0 nM) than the equivalent human domain
(Kd = 2360.9 nM). Furthermore, AgCPR was an order of magnitude more sensitive than hCPR to the reductase inhibitor
diphenyliodonium chloride (IC50 = 28 mM62 and 361631 mM respectively). Taken together, these results reveal unusual
biochemical differences between mosquito CPR and the human form in the binding of small molecules that may aid the
development of ‘smart’ insecticides and synergists that selectively target mosquito CPR.
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Introduction
The mosquito Anopheles gambiae ‘is the principal vector for
malaria in sub-Saharan Africa, a disease that affects over 500
million people worldwide. Insecticides have been the mainstay of
disease control programmes in disease endemic countries for
many years. However, these are threatened by the rapid
evolution of insecticide resistance in disease vectors [1]. An
important mechanism of resistance is enhanced metabolic
inactivation of insecticides by P450s [2], a diverse superfamily
of heme-containing monoxygenases that catalyse a diverse range
of chemical reactions important in developmental processes and
for detoxification of foreign compounds. It is well known that
inhibiting P450 activity can help overcome resistance by
potentiating insecticidal activity. Indeed piperonyl butoxide, a
broad spectrum P450 inhibitor, is being increasingly used to
extend the lifetime of pyrethroids, the only class of insecticide that
can be safely used for insecticide treated bednets, in areas where
resistance is undermining malaria control [3]. P450s are located
in the endoplasmic reticulum where they require electrons
supplied by NADPH cytochrome P450 oxidoreductase (CPR)
for catalysis [4] placing this protein in a critical path in
metabolism-based insecticide resistance, and a novel target for
the development of new chemical synergists.
CPR is a ,80 kDa microsomal diflavin reductase that contains
flavin mononucleotide (FMN) and flavin adenenine dinucleotide
(FAD) cofactors that shuttle electrons from the reduced form of
NADPH through a series of redox-coupled reactions to P450 [4];
other physiological electron acceptors, include cytochrome b5,
[5,6], squalene hypoxidase [6] and heme oxygenase [7,8]. The
crystal structures of yeast [9,10] and rat CPR have been resolved
[11] revealing a structurally high conserved molecule with three
separable domains: a short hydrophobic N-terminal membrane
anchoring region (,60 amino acids), essential for P450 coupling,
followed by FMN-binding and FAD/NADPH-binding domains
homologous to flavodoxin and ferrodoxin-NADP+ reductase
respectively [11].
Despite its great medical importance, there is relatively little
known about the biochemistry and function of the individual
components of the P450 complex of A. gambiae. Most recently,
CPR from the mosquito A. minimus has been characterised [12,13].
The mosquito enzyme shared close biochemical similarities with
other CPR family members (Figure 1), although weak binding
FMN and FAD cofactors [12] points to potential species
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differences. We have mapped the tissue distribution of CPR in A.
gambiae and discovered high levels of expression in specialised
mosquito cells (oenocytes) that suggests key physiological roles for
CPR in metabolic processes and pheromone production/metab-
olism [14]. As expected, CPR gene knockdown by RNAi greatly
increases the susceptibility of A. gambiae to permethrin, a widely
used pyrethroid insecticide, emphasising the important chemo-
protective role of the P450 monooxygenase complex in this
Figure 1. Sequence alignment of human and mosquito CPR. Cofactor binding sites are as defined by Wang et al [11]. Conserved residues
associated with 29-phosphate binding (S596, R597, K602 and R634 [17,32]) are shown with an asterisk. The FMN binding domain spanning amino
acids E69 to G254 that was expressed in E. coli is underlined.
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organism [14], and validating its potential as a target for the
development of chemical inhibitors that might enhance insecti-
cidal activity.
Here we have expressed AgCPR and the equivalent human
isoform in E.coli in order to allow direct comparisons of cofactor
binding and steady-state kinetics. This has identified significant
differences in the binding of 29, 59-ADP and FMN that suggest a
potential target for the design of new insecticides or synergists to
combat malaria.
Materials and Methods
Cloning, expression and purification of D63AgCPR
The cloning of AgCPR cDNA was previously described [14,15].
The membrane anchor sequence was deleted by removal of amino
acids 2–63 by PCR, using PFU polymerase (Stratagene) and the
following oligonucleotides; forward primer: 59- CGCG GAT CCG
ATG ACG ATG ACG ATG GTG GAG ACC - 39and reverse
primer: 59- TTC GGA TCC TTA GCT CCA CAC GTC CGC
CGA – 39 (BamHI sites are underlined and the respective start and
stop codons are indicated in bold). For molecular dissection of D
63AgCPR into its individual FMN- binding domain, PCR was
used to amplify the amino acid residue region E69 to G254 using
the following oligonucleotides: forward primer: 59-CCATGGA-
GAACTCGTTCATCAAGAAGC – 39 (NcoI site is underlined)
and revese primers: 59- CCATGGTTACTCGCCGGTGTA-
GATGC – 39 (KpnI site underlined). The FMN –binding region
expressed is underlined in Figure 1. The PCR product was
digested with Kpn1 and Nco1 and subcloned into the expression
vector pETM-11 which contained a TEV protease cleavage site.
Constructs were confirmed by DNA sequencing. All proteins were
expressed in E. coli strain BL21-CodonPlus(DE3)-RP strain at
30uC and purified using standard Ni2+-affinity chromatography
and elution with 250 mM imidazole [16]. Thrombin (2000:1(w/w)
protein:thrombin for AgCPR) and TEV protease (20:1(w/w)
protein:TEV protease for the FMN binding domain) were,
respectively, used to remove the His-tag from D63AgCPR. For
thrombin cleavage, the sample was incubated for 2 hr at room
temperature, whereas for TEV cleavage, overnight incubation at
room temperature was required. The samples were reapplied to a
Ni2+-affinity column to removed free his-tags and uncut protein.
The samples were desalted in the presence of an excess of FMN and
FAD and further purified using a 5 mL HiTrap Q FF anion
exchange column (GE Healthcare) followed by MonoQ 5/5 anion
exchange column (GE Healthcare). For final purification and buffer
exchange, size exclusion chromatography was performed using a
HiLoad 26/60 Superdex 75 column (50 mM Tris-HCl (Melford),
50 mM NaCl; pH 7.0). The human form, hCPR, was purified as
described by Dohr [17]. Protein purity was .95% as assessed by
SDS-PAGE and all samples were verified by mass spectrometry.
Protein concentration was calculated by Bradford assay.
Spectral Analysis
Absorption spectra of the purified CPR were carried out with a
Cary 300 Bio and Cary 4000 spectrophotometers [18]. The
sample buffer was 100 mM Tris, pH 8.0.
Flavin content determination
Flavin cofactors (FMN and FAD) were released from AgCPR by
heat denaturation (Paine et al, 1999). Briefly, 100 mL AgCPR
(0.1 mg/mL) was incubated at 95uC for 5 min, centrifuged at
room temperature at 20, 0006g for 5 min and the supernatant
analysed for flavin content by HPLC analysis. 10 mL sample (or
standards) were loaded into a mobile phase of 50 mM ammonium
acetate; pH 4.5 with 20% (v/v) acetonitrile for separation on a
250 mm C18 column (AcclaimH120, Dionex) at 23uC. The flow-
through was analysed by absorption spectroscopy and fluorescence
(excitation 450 nm, emission 525 nm). Quantification was deter-
mined with reference to authentic FMN and FAD standards
(Sigma).
Cytochrome c and NADPH kinetics. The rate of change of
absorbance of horse heart cytochrome c (Sigma-Aldrich, UK) at
550 nm was measured at 25uC using a Cary 4000 UV-Visible
spectrophotometer essentially as described [17]. For cytochrome c
kinetics, 0.75 pmol purified AgCPR or hCPR was pre-incubated
with 0–110 mM cytochrome c (dissolved in 0.3 M potassium
phosphate buffer; pH 7.7 or 0.1 M Tris-HCl, pH 7.7/0.1 M KCl)
in a total volume of 500 ml for 2 min at 25uC. Reactions were
initiated by the addition of NADPH to a final concentration of
50 mM and rates measured in duplicate for 2 mins, a linear
reaction range. For determination of NADPH kinetic parameters,
the cytochrome c concentration was kept constant at 50 mM, and
reactions were initiated with 0–150 mM NADPH.
Inhibition measurement
Cytochrome c. Measurement of cytochrome c reduction was
carried out at 25uC with 50 mM cytochrome c and 0.75 pmol
purified AgCPR or hCPR essentially as described [17] using
0.3 M potassium phosphate buffer, pH 7.7 or 0.1 M Tris-HCl,
pH 7.7/0.1 M KCl, and different concentrations of 29, 59-ADP,
29-AMP, NADP or diphenyliodonium chloride (all from Sigma-
Aldrich, UK). For phosphate buffer reactions AgCPR and hCPR
reactions were initiated by the addition of 30 mM or 15 mM
NADPH respectively, corresponding to their apparent Km values;
for Tris buffer reactions respective NADPH concentrations were
12 mM and 5 mM.
Isothermal Titration Calorimetry (ITC)
ITC experiments were performed using a ITC200 microcalo-
rimeter (Microcal Inc/GE Healthcare). Protein samples were
dialysed into 100 mM BES; pH 7.0 from 50% glycerol stocks
stored at 220uC. The concentrations of all the proteins were
determined by using Bradford assay. Samples were centrifuged at
13,0006g for 10 min and degassed at 23uC (2uC below the
temperature at which the experiments were performed). All
experiments were performed at 25uC. Typically, the protein
concentration in the cell was 10–20 mM whilst ligand concentra-
tions were in the range of 100–1000 mM. The data analysed using
Origin 7.0 (Microcal) after subtracting the heats of dilution
obtained from parallel experiments performed by injecting the
nucleotide into the buffer. Thermodynamic parameters n (stoichi-
ometry), Kd (1/Ka, the association constant), and DuH (enthalpy
change) were obtained by nonlinear least-squares fitting of
experimental data using the single-site binding model. The free
energy of binding (DGu) and entropy change (DSu) were obtained
using eqs 1 and 2.
DGu=2RT ln KA (1)
DGu=2DHu-TDSu (2)
Results
Expression and purification of AgCPR and flavin-binding
domains
Initial attempts to purify full-length AgCPR expressed in E. coli
using standard ion exchange and 2, 59-ADP-Sepharose affinity
chromatography [19,20] failed, which suggested that AgCPR
might have different nucleotide binding properties. Therefore, to
Comparison of Mosquito and Human CPR
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examine this further N-terminally histidine tagged soluble forms,
lacking the N-terminal membrane anchor, of AgCPR was expressed
in E. coli and affinity purified over nickel agarose (Fig. 2A). Although
CPR lacking the amino-terminal membrane anchor loses its ability
to interact with P450 it is otherwise fully functional and capable of
reducing a range of electron acceptors [11]. Equivalent preparations
of human anchorless CPR were also produced [17], and
comparative enzyme activities measured via the reduction of
cytochrome c, the surrogate electron acceptor most commonly
used for measuring diflavin reductase activity [21].
Purified AgCPR was yellow, indicating the binding of flavin
cofactors. AgCPR contained 0.7260.01 mol of FMN and
0.8060.01 mol of FAD per mol of enzyme. This compared with
0.8860.03 mol of FMN and 0.9260.02 mol of FAD per mol of
hCPR enzyme purified under the same conditions, and somewhat
higher than those for A. minimus (0.51 and 0.63 mol FMN and
FAD per mol enzyme respectively) [12]. The optical spectrum of
the oxidised enzyme was typical for a diflavin reductase with
absorbance maxima at 379 nm and 454 nm (Fig. 2 B). The
addition of a stoichiometric amount of NADPH produced a
characteristic increase in the 500–650 nm region, associated with
the formation of an air-stable flavin semiquinone as for human
[22] and insect CPRs [12,23]. The appearance of a peak in the
340–350 nm region in the semi-quinone form associated with
NADPH oxidation similar to humans [24] was also evident.
Comparison of Nucleotide Binding
Since AgCPR appeared to bind weakly to 29, 59-ADP the
binding properties of this molecule were examined in more detail.
29, 59-ADP is the adenosine-ribose moiety of NADPH, which
binds through a bi-partite mode with the nicotinamide moiety, to
separate binding pockets of CPR [17]. Thus to delineate the roles
played by the nicotinamide and ribose moieties, we used
isothermal titration calorimetry (ITC) to determine the binding
affinities of the adenosine-ribose fragments (Table 1). As previously
reported for hCPR [25], this was done in a phosphate-free buffer
to prevent competitive interactions with free phosphate. Figure 3
represents the ITC binding isotherms resulting from the titration
of AgCPR with 29, 59-ADP, NADP+ and 29-AMP. The binding
isotherms were exothermic and fit to a single-site model. The
Figure 2. Purification a spectral characterisation of AgCPR. A, SDS-polyacrylamide gel electrophoresis of AgCPR purified by nickel-agarose
affinity chromatography. Lane 1, molecular weight standards (kDa); Lane 2, partially purified CPR fraction eluted with 250 mM imidazole; Lane 3,
thrombin cleaved AgCPR. B. absorption spectra of purified AgCPR(1.5 mM). Trace a is the oxidised spectrum; Trace b is the reduced spectrum with
1.5 mM NADPH and measured after 10 seconds; trace c is the air-stable semiquinone measured after 30 min.
doi:10.1371/journal.pone.0020574.g002
Table 1. Measured thermodynamic parameters for AgCPR and hCPR interactions with a selection of nucleotide ligands.
Ligand na Kobs (610
5 M21) Kd (nM)
b DH (kcal mol21) TDS (kcal mol21) DG (kcal mol21)
AgCPR
NADP+ 1.0060.04 27.561.29 363617 211.9760.64 23.24 28.73
29,59-ADP 1.0160.03 24.461.07 410618 213.1360.35 24.73 28.40
29-AMP 1.0160.22 2.5160.11 40006175 27.6661.98 22.19 25.47
hCPR
NADP+ 1.0160.12 145624.5 69612 219.4662.92 28.91 210.55
29,59-ADP 1.0060.02 263626.3 3863.8 220.3660.53 29.97 210.39
29-AMP 1.0260.06 6.1561.69 16006440 211.0760.88 23.21 27.86
Experiments were performed at 25uC in 100 mM BES; pH 7.0.
aBinding stoichiometry.
bKd = 1/Kobs.
doi:10.1371/journal.pone.0020574.t001
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observed dissociation binding constant for the AgCPR - 2959-ADP
interaction was 410618 nM, with a binding stoichiometry
n= 1.03. This is substantially weaker than hCPR under the same
reaction conditions (Kd of 3863.8 nM; this study and [25]).
The binding affinity of NADP+ was ,5-fold weaker for AgCPR
(Kd= 363617 nM) versus its human equivalent hCPR
(Kd= 69612 nM), while 29-AMP binding was analysed to confirm
the importance of the 29-phosphate to nucleotide interaction with
CPR. As expected the binding strength was orders of magnitude
lower than 29-59-ADP and NADP+. Nevertheless a modest two-
fold decrease in the apparent affinity for 29 AMP in the mosquito
protein (Kd of 460.18 m M vs human 1.660.44 m M), was
measurable which compared to 2959-ADP suggest that interactions
with the 59 phosphate group make significant contributions to the
binding affinity of the adenosine ribose moiety.
The enthalpy change (DH) for hCPR binding to 29,59-ADP was
220.36 kcal mol21 was higher than for A. gambiae CPR binding
(DH=213.13 kcal mol21) (Table 1). This is consistent with the
lower dissociation constant value, and a further indication that the
energetics of 29,59-ADP binding are more favourable with the
human enzyme. Likewise, the DH for NADP+ binding to hCPR
was approximately 2 fold lower than AgCPR (219.46 kcal mol21
vs 211.97 kcal mol21). Finally, differences were minimal with
respect to the energetics of 29-AMP binding.
In summary, AgCPR binds all the nucleotide analogues more
weakly than hCPR. Secondly, for both proteins, the small
difference in affinities of each protein for NADP+ and 29, 59-
ADP, suggests that in both the human and Anopheles gambiae
proteins, the nicotinamide moiety makes only minimal contribu-
tion to the binding surface. From a structural viewpoint, it is likely
that the conformations around the NADPH binding site in
Anopheles gambiae CPR are similar to those already discovered for
the mammalian proteins [10].
Comparison of FMN Binding
The binding affinity of FMN to the isolated FMN-binding
domains of both A. gambiae and hCPR were also examined by
titration of the apo-FMN binding domains (Figure 4). Both
isotherms show reasonable binding and saturation of the apo-
proteins is achieved with excess flavin. The Kd for FMN binding to
the isolated apo-human FMN-binding domain was calculated to
be 2360.9 nM which is almost 4-fold stronger than for the
isolated apo-A. gambiae FMN-binding domain which was calculat-
ed to be 8362.0 nM.
Figure 4. Isothermal titration of FMN domains with FMN. Binding isotherms for the titration of FMN into AgCPR. The points are fit to a one-
set-of-sites model. Reaction were carried out in BES buffer (100 mM, pH 7.0 and 25uC) as described in Materials and Methods. The thermodynamic
parameters of DS, DG, DH, and Kd are listed in Table 2.
doi:10.1371/journal.pone.0020574.g004
Figure 3. Isothermal titration of oxidized AgCPR with 29, 59 – ADP. Binding isotherms for the titration of 29,59-ADP into AgCPR. The points are
fit to a one-set-of-sites model. Reactions were carried out in BES buffer (100 mM, pH 7.0 and 25uC) as described in Materials and Methods. The
thermodynamic parameters of DS, DG, DH, and Kd are listed in Table 1.
doi:10.1371/journal.pone.0020574.g003
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The thermodynamic characteristics (Table 2) also heavily
favoured FMN binding to the human FMN-binding domain over
the A. gambiae FMN-binding domain. The DH for FMN binding to
the human FMN-binding domain was 219.4660.35 kcal mol21,
which is more favourable than the213.1860.19 kcal mol21 which
was measured for the A. gambiae FMN-binding domain. The DG for
FMN binding to the human FMN-binding domain was
210.28 kcal mol-1 suggesting the binding of FMN flavin to human
FMN-binding domain is more favourable than to A. gambiae FMN-
binding domain which had a calculated DG of 29.60 kcal mol21.
Kinetic comparisons between AgCPR and hCPR
To compare activities, standard phosphate buffer conditions
that give optimal hCPR activity were initially used [17]. The
specific activity of purified AgCPR was 23.9 mmol/mg/min
compared with 18.3 mmol/mg/min for hCPR. Both AgCPR
and hCPR catalysed NADPH-dependent cytochrome c reduction
following Michaelis-Menton kinetics with respect to substrates
cytochrome c and NADPH. The Km
cytc values for human and
mosquito enzymes were 19 mM and 23 mM respectively, indicat-
ing similar binding affinities for cytochrome c. There was a slight
decrease in affinity of the mosquito CPR for the NADPH cofactor
relative to the human protein (KM
NADPH 30.0 mM vs 16.0 mM
respectively). Rates of cytochrome c reduction were alike,
characterized by turnover numbers (kcat) of 105 s
21 and 88 s21
respectively for mosquito and hCPRs and near the range of 50–
100 sec21 noted for most CPRs [20]. Interestingly, the turnover
rate for AgCPR is ,4 fold higher than that reported for A. minimus
CPR (23.8 s21) [12], possibly attributable to the low stoichiometry
of FMN in A. minimus CPR. Overall, however, close functional
similarities were found with between human and A. gambiae CPR
with respect to the steady state kinetics of cytochrome c reduction.
Comparison of cytochrome c reductase inhibition by 29,
59-ADP
29,59-ADP, 29-AMP and NADP+ were used as inhibitors of
CPR catalyzed reduction of cytochrome c to determine whether
the observed difference in ITC dissociation constants (Kd) for
complexes formed with 29,59-ADP were manifest as variations in
inhibition (IC50) of catalytic activity (Table 3). Consistent with the
lack of binding to 29, 59-ADP Sepharose, the major difference
observed in phosphate buffer was a ten-fold decrease in affinity for
29, 59 - ADP, which inhibited AgCPR with an IC50 value of
262 mM compared with 28 mM for hCPR. There was also a two-
fold increase in affinity for 29 AMP (mosquito 468 mM vs human
1085 mM), while no significant differences were observed for
NADP (mosquito 129 mM vs human 105 mM).
Since the binding affinity for NADPH is reduced in the
presence of high phosphate concentrations [26], which may have
influenced the data, we also investigated IC50 reactions in a
phosphate-free Tris buffer (Table 3). Under these conditions we
observed a ,3 fold decrease in KMNADPH values, relative to
phosphate buffer, for human and mosquito enzymes (5.1 mM and
12.4 mM respectively), as well as corresponding decreases in Kcat to
46.7 sec21 and 57.5 sec21 respectively, and a general decrease in
IC50 values (Table 3). However, the 29, 59-ADP affinity for
mosquito CPRs remained significantly lower (6 fold) than human.
Differences in 29-AMP and NADP IC50 values were negligible.
Finally, we also compared the inhibitory effects of diphenylio-
donium chloride, a widely used inhibitor of CPR and related
enzymes [27], on cytochrome c reductase activity. A difference of
the same magnitude as that observed with 29, 59-ADP but in the
opposite direction was also discovered: AgCPR is one order of
magnitude more sensitive than hCPR to diphenyliodonium
chloride (Table 3). Taken together, these results reveal significant
biochemical differences between mosquito CPR and the human
form in the binding of the small molecules 29, 59-ADP and
diphenyliodonium chloride.
Discussion
In view of the paucity of public health insecticides there is a
pressing need to understand the mechanisms of detoxification and
identify targets for new insecticides against disease vectors, in
particular A. gambiae. Shutting down P450 activity is an attractive
option since it can block resistance thereby extending the lifetime
of insecticides already in use, as proven with the P450 inhibitor
piperonyl butoxide[3]. Being the obligate redox partner for
microsomal P450s, undermining Anopheline CPR activity is an
attractive target provided it can be selectively inhibited. Although
numerous CPRs have been characterised, few if any side-by-side
comparisons have been made. Our direct comparative biochem-
ical analysis of A. gambiae and human CPRs has revealed
substantial differences in co-factor binding which may aid design
of species specific CPR inhibitors. Of particular note was the weak
affinity of AgCPR for 29, 59-ADP, reflected in the lack of binding
to 29, 59-ADP affinity matrix and, ,6–10 fold higher IC50 value
compared to hCPR for cytochrome c reduction and ,10 fold
higher dissociation binding constant (Kd = 410 nM vs 38 nM for
hCPR). This is significant since, for other CPRs, 29,59-ADP
binding exerts conformational changes affecting electron transfer
rates [25,28,29], while 29-phosphate is the major contributor to
the high affinity binding of NADPH to CPR [25], 25].
The results here also show that the A. gambiae protein binds the
nucleotide analogues in ways similar to the human one (hCPR),
with the nicotinamide moiety making only modest contributions to
the binding surface. In the crystal structure of the rat reductase,
NADP+ was found to bind in multiple conformations. It is,
therefore, difficult to precisely identify the residues that might be
important for nucleotide binding for the human protein which
could provide clues as to why the binding affinities to Ag CPR are
different. At this stage, we postulate that the considerably weaker
binding of 29,59-ADP to AgCPR could have a significant influence
on enzyme function
Differences also extend to FMN binding, where AgCPR again
shows ,4 fold weaker affinity against hCPR (Kd 23 nM vs 83 nM
respectively). Interestingly, AgCPR is much more (,10 fold)
Table 2. Measured thermodynamic parameters for A. gambiae and hCPR interaction with FMN.
apo-FMN domain na Kobs (610
5 M21) Kd (nM)
b DH (kcal mol21) TDS (kcal mol21) DG (kcal mol21)
Human 1.0060.01 438617.5 2360.9 219.4660.35 22.90 210.28
A. gambiae 0.9860.01 12063.19 8362.0 213.1860.19 23.58 29.60
Experiments were performed at 25uC in 100 mM BES.
doi:10.1371/journal.pone.0020574.t002
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sensitive to diphenyliodonium chloride inhibition than hCPR.
While there appears no obvious effect on cytochrome c reductase
activity (the steady state kinetics AgCPR being comparable to
hCPR), we have not compared activity with other redox partners
such as P450s and heme oxygenase, where functional differences
may be more pronounced. Indeed, given that heme degradation in
mosquitoes is vital for survival with a blood feeding habit, and
heme oxygenase is closely involved in heme degradation [30], it is
feasible that biochemical differences in CPR may reflect
differences in redox partner interactions. This hypothesis is
supported by the fact that methionine synthase reductase, a
diflavin reductase closely related to CPR, has a low affinity binding
mode for 29, 59 –ADP (,500 nM) [31].
An important question arising from this work is to what extent
the observed differences in affinity of AgCPR for the adenosine,
flavin and diphenyliodonium chloride molecules reflect intrinsic
structural and/or mechanistic differences with respect to CPRs
from human and other species. Since interactions involving 29-
phosphate are the major contributor to the high affinity binding of
NADPH to CPR [26] we might expect differences in 29, 59-ADP
to be associated with this phosphate molecule. However, the
amino acids proposed to make up the 29-phosphate binding motif
including serine 596, arginine 597, lysine 602 and arginine 634
[17,32] are conserved in A. gambiae CPR. Furthermore, these may
prove difficult to resolve through X-ray crystallography due the
inherent flexibility of this region in the CPR enzyme family [11].
The three-dimensional structures of the rat [11] and yeast [9]
CPR and the rat nNOS FAD domain [33] have collectively
provided details of the cofactor binding sites for the oxidoreduc-
tases. FMN binds in the region 139TYGEGPD and
175NKTYEHFN (rat CPR numbering), with Y140 and Y178
sandwiching the FMN isoalloxazine ring, and F181 stabilising the
cofactor binding [34]. We have performed a multiple sequence
alignment of AgCPR with A. minimus CPR, rat CPR, S. cerevisiae
CPR and rat nNOS reductase domain (Fig. S1). As far as AgCPR
is concerned, the residues mentioned above are all conserved with
the exception of F181 (in rat CPR) replaced by Y184 (in AgCPR).
However, it had previously been reported that mutation of F181 to
Y181 in hCPR had minimal effects on FMN binding and
enzymatic activity [34]; hence, replacing the tyrosine residue in
AgCPR protein is of little consequence for FMN affinity.
Therefore, despite the availability of good structures of homolo-
gous proteins, these have so far proved inadequate for under-
standing the cofactor binding characteristics of the AgCPR.
Determination of the FMN-binding domain of AgCPR is in
progress.
Finally, the greatly increased sensitivity of AgCPR for
diphenyliodonium chloride may be related to increased rates of
internal electron transfer, possibly linked to differences in redox
potentials. Diphenyliodonium chloride inhibition is proposed to
occur through an NADPH dependant reductive mechanism
whereby diphenyliodonium chloride receives an electron from a
reduced flavin to produce a reactive phenyl radical that
recombines with FMN in its semiquinone state, creating an
inactive phenylated FMN adduct [27].
Conclusion
Overall, these results reveal significant biochemical differences
between mosquito CPR and the human form in the binding of the
small molecules 29, 59-ADP and diphenyliodonium chloride.
Importantly, the low affinity of mosquito AgCPR for 29, 59-ADP
and FMN and high affinity for diphenyliodonium chloride
distinguishes it from human CPR, which offers the possibility of
designing molecules to specifically inhibit mosquito CPR function.
A potential advantage is that being encoded by a single gene that
has a house-keeping role in furnishing electrons to all microsomal
P450s, its inhibition is likely to be lethal to early development
stages, giving it potential insecticidal properties in its own right.
Notwithstanding the obvious challenges of designing molecules
based on selective recognition of the NADPH binding pocket,
these results suggest that detailed analysis of the structure and
function of mosquito CPR may help in the development of ‘smart’
molecules that could specifically target mosquito vectors of major
human diseases such as malaria. Finally, the importance of
comparing AgCPR co-factor binding properties with other lentic
invertebrate species must be emphasized as close similarities could
limit the efficacy of inhibitors by collateral damage to non-target
species.
Supporting Information
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binding (light grey) and stabilisation (dark grey) are highlighted.
Sequences were aligned using ClustalW.
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